Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001192482-20-000761

Options or other derivatives

  • Chief Executive Officer acquired 76,674 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

COLA MICHAEL F · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-10-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +76,674 $2.24 2030-10-01 76,674 76,674 D
Loading xslF345X03/edgar.xml…